LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing,Cyclopentanohydrophenanthrene ring system doai

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

26-aminocholesterol and derivatives and analogs thereof in the r

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

3,17 .beta.-estriol diesters, methods of their use, and pharmace

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

3,5-Disubstituted-[1,2,4]-oxadiazoles and analogs as...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

3,6-dihydroxy-24-amidyl steroid derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

3-Keto-19-nor-.DELTA..sup.4,9 -steroids

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

3-keto-nor-pregnenes substituted in the 6-position and treatment

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

3-methylene steroid derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

3-methylene-4-androsten-17-ones, process for their production an

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

3-nitrogen-6, 7-dioxygen steroids and uses related thereto

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

3-nitrogen-6,7-dioxygen steroids and uses related thereto

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

3-substituted nitro-steroid derivatives as 5-.alpha.-reductase i

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

3.beta.,17.beta.-hydroxy-substituted steroids and related steroi

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

4- Halogenated steroids, preparation method and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

4-amino androstendione derivatives and process for their prepara

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

4-amino-.DELTA..sup.4,6 -steroids and their use as 5.alpha.-redu

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

4-amino-.DELTA.4-steroids and their use as 5.alpha.-reductase in

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

4-amino-17.beta.-(cyclopropyloxy)androst-4-en-3-one, 4-amino-17.

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

4-halogenated steroids, their preparation process and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

4-substituted 17.beta.-(cyclopropylamino)androst-5-en-3.beta.-ol